Scroll for more

news

Mar 28, 2018 announcements

Medical AI Award sets its sights on treating Parkinson's

A collaboration between Parkinson's UK and The Cure Parkinson's Trust (CPT) to identify new treatments for Parkinson's has been awarded the inaugural BenevolentAI Award. Presented through a competition run with the Association of Medical Research Charities (AMRC), the award offers a selected charity AI-driven R&D support from BenevolentAI, one of Europe's largest private AI companies.

Feb 22, 2018 announcements

BenevolentAI acquires advanced Cambridge research facility to accelerate its AI-enabled drug development

Acquisition creates first AI company capable of covering entire drug development process from drug discovery to clinical development Cambridge research facility will advance BenevolentAI drug programmes into the clinic more quickly and at a much larger scale.